Chris Wittenborn

Chris Wittenborn

Trading-Equity at Frazier Life Sciences Management LP

Finance
Consumer Services

Profile

Mr. Christopher D.
Wittenborn is a Trader at Frazier Life Sciences Management LP.
He joined the Frazier Life Sciences team as a Trader in April 2021 and focuses on trade execution as part of Frazier’s public portfolio management.
Prior to joining Frazier, he was the CEO of a FINRA registered Broker Dealer that garnered one of the first approvals for transacting in digitized private market securities on an SEC Registered Alternative Trading System (“ATS”).
Previously, he was a trader at Point72 Asset Management where he focused on public Biotechnology companies.
Before Point72, he was a Director at Leerink Partners (now SVB Leerink), where he spent six years focused on market making in Biotech and Generic Pharmaceuticals companies.
He began his career in Special Situations Research and transitioned to trading by managing the pre- and post-trade analytics for a program trading desk responsible for transacting on behalf of large pension funds.
Mr. Wittenborn earned a Bachelor of Science (Finance) in Business at the University of Colorado at Boulder where he was a member of the Dean’s Cabinet for the Business School.

Chris Wittenborn active positions

CompaniesPositionStart
Trading-Equity 2021-03-31
All active positions of Chris Wittenborn

Former positions of Chris Wittenborn

CompaniesPositionEnd
Analyst-Equity 2010-08-23
See the detail of Chris Wittenborn's experience

Training of Chris Wittenborn

The University of Colorado Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Chris Wittenborn's experience

Connections

1

1st degree connections

3

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies2

Finance

Finance

See company connections
  1. Stock Market
  2. Insiders
  3. Chris Wittenborn